Contact Us
Drug Search Results
More Filters [+]

Dequalinium chloride

Alternative Names: dequalinium chloride, dequadin
Latest Update: 2024-05-14
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Gram+ Bacteria Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Vaginal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | Belgium | Brazil | Bulgaria | Chile | Colombia | Dominican Republic | Egypt | France | Germany | Hong Kong | Hungary | Indonesia | Ireland | Italy | Lebanon | Malaysia | Mexico | New Zealand | Pakistan | Philippines | Portugal | Russia | South Africa | Spain | Sri Lanka | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Medinova AG
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dequalinium chloride

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Vaginal Diseases|Vaginosis, Bacterial|Candidiasis, Vulvovaginal

Phase 3: Vaginosis, Bacterial|Vaginal Diseases|Gram-Positive Bacterial Infections|Pseudomonas Infections|Gram-Negative Bacterial Infections

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
MNFM380119

P4

Terminated

Vaginosis, Bacterial|Vaginal Diseases

2022-08-25

2020-002489-15

P4

Terminated

Vaginosis, Bacterial

2022-08-15

DEVA

P4

Unknown status

Vaginosis, Bacterial

2022-03-22

NCT04057482

N/A

Completed

Vaginosis, Bacterial|Vaginal Diseases

2017-12-01

Recent News Events

Date

Type

Title

05/14/2024

PubMed

 Dequalinium chloride vaginal tablets for recalcitrant Trichomonas vaginalis: A case report.

05/01/2024

PubMed

 Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial.

05/01/2024

PubMed

 Dequalinium Chloride-An Emerging Option in the Sparse Landscape of Bacterial Vaginosis Therapies.

09/05/2023

News Article

 The Sore Throat Lozenges market is projected to experience growth in the forecast period of 2023 to 2030, as shown by new trend analysis and competition tracking, with a CAGR of 5.8%.

07/05/2023

News Article

 Norwell Consumer Healthcare Announces Asset Acquisition of Boyd Pharmaceuticals

06/21/2022

News Article

 Duchesnay announces the launch of Vablys® (dequalinium chloride vaginal tablets), an antiseptic and anti-infective treatment for bacterial vaginosis

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions